The University of Kansas Hospital Cambridge North Tower A — Kansas City, Kansas

The University of Kansas Hospital Cambridge North Tower A is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Kansas Hospital Cambridge North Tower A has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Adenocarcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Hospital Cambridge North Tower A?

The University of Kansas Hospital Cambridge North Tower A has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Hospital Cambridge North Tower A conducted?

The University of Kansas Hospital Cambridge North Tower A has 3 clinical trials on record, with 3 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Adenocarcinoma.

Is The University of Kansas Hospital Cambridge North Tower A accredited by Crixeo Health?

The University of Kansas Hospital Cambridge North Tower A has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Hospital Cambridge North Tower A?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.